Mimedx (MDXG) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.52% |
| Dec 31, 2025 | -11.64% |
| Sep 30, 2025 | -5.33% |
| Jun 30, 2025 | -19.79% |
| Mar 31, 2025 | -14.75% |
| Dec 31, 2024 | -8.62% |
| Sep 30, 2024 | 1.16% |
| Jun 30, 2024 | 6.56% |
| Mar 31, 2024 | -11.31% |
| Dec 31, 2023 | -12.69% |
| Dec 31, 2022 | -19.14% |
| Sep 30, 2022 | -14.92% |
| Jun 30, 2022 | -8.81% |
| Mar 31, 2022 | -19.60% |
| Dec 31, 2021 | -23.49% |
| Sep 30, 2021 | -37.65% |
| Jun 30, 2021 | -28.99% |
| Mar 31, 2021 | -36.91% |
| Dec 31, 2020 | -26.74% |
| Sep 30, 2020 | -18.16% |
| Jun 30, 2020 | -1.00% |
| Mar 31, 2020 | -3.66% |
| Dec 31, 2019 | -5.71% |
| Sep 30, 2019 | -14.78% |
| Jun 30, 2019 | -19.81% |
| Mar 31, 2019 | 7.98% |
| Dec 31, 2018 | -0.47% |
| Dec 31, 2017 | -32.40% |
| Sep 30, 2017 | -36.81% |
| Jun 30, 2017 | -78.07% |
| Mar 31, 2017 | -59.23% |
| Dec 31, 2016 | -49.11% |
| Sep 30, 2016 | -95.80% |
| Jun 30, 2016 | -71.29% |
| Mar 31, 2016 | -76.78% |
| Dec 31, 2015 | -85.31% |